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ABSTRACT: 
 
The drawbacks of nonactin, the current commercial standard receptor for 
ammonium ion necessitate the development of new ammonium 
ionophores. We have designed and attempted to synthesize 
fluoroionophores, I- III. Molecular modeling of I suggests superior 
selectivity over that of nonactin. III was synthesized as a selective 
ionophore for optical detection of ammonium ion. The synthetic strategies 
for III  are two-fold: solid phase and solution phase. Solution phase 
synthesis was performed with two different protecting groups (t-butyl 
ester and benzyl ester). A methyl-amino substituted anthracene molecule 
will be covalently coupled to the secondary amine group to provide an 
optical signaling moiety that operates on the basis of an “off-on” 
fluorescence emission mechanism. Compound IV was also synthesized in 
order to provide a sample reaction for the covalent coupling of the 
chromophore and to provide a fast route to an ammonium 
fluoroionophore.  
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INTRODUCTION: 
 
Over the past several decades, there has been continued interest in 
developing sensors, either electrochemical or optical, for ammonium 
cations (NH4+). The ammonium ion can be produced by the enzymatic 
conversion of urea and other nitrogen containing molecules (creatinine, L-
phenylalanine, adenosine) found in the blood (Blood Urea Nitrogen or 
BUN). Its detection, then, is an important diagnostic for disease, 
particularly kidney disease. [1, 4, 8, 11, 13, 15] The ammonium ion is also 
an indicator for environmental contamination. For these reasons - clinical 
diagnostic and environmental monitoring - much effort has been expended 
in the development of ammonium ion sensors.  
 
In clinical diagnostic applications, ammonium sensors consist of a 
molecule with an ammonium complexation site that is incorporated into a 
membrane plus a second membrane that contains an enzyme or enzymes 
that are capable of converting molecules containing amine and amides to 
ammonium ion. See for example, scheme 1. 
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Scheme-1: Enzymatic Degradation of urea and creatinine 
 
Several compounds have been synthesized and identified previously as 
ammonium ion-selective ionophores. In particular, Lehn et al [2, 3, 7] 
investigated the ammonium binding properties of SC-24 and  SC-25, 
macrotricyclic cryptands shown in Figure 1.   
  
 
Figure 1: Structures of SC-24 and SC-25 
 
 11
In these molecules, the ammonium cation is bound by a tetrahedral array 
of N+-H----N hydrogen bonding sites and by 10 electrostatic interactions 
to the five oxygens in SC-25 and 12 electrostatic interactions to the six 
oxygens in SC-24 [2, 7]. The most stable position of the NH4+  is centered 
inside the cavity with N+-H----N = 3.13 Ao ).[7] Despite high NH4+/ K+ 
selectivity of SC-24(NH4+/K+ = 500)[7] and SC-25 (NH4+/K+ = 63) [7], a 
characteristic that is required for efficient sensing, the complexation 
equilibrium constant is extremely high, making these molecules 
ammonium ion sinks and useless as sensors.   
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Figure-2: Structure of Thiazole containing dibenzo-18-crown-16 
(TDB18C6) 
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Kim et al [15] synthesized the thiazole-containing dibenzo-18-crown-6 
shown in Figure 2. This molecule provides both an appropriate sized 
cavity and binding interactions that are conformationally                                  
favorable for binding ammonium ion. Enhanced selectivity over alkali 
metal ions, particularly potassium which has a similar atomic radius to 
ammonium ion, was reported.  
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Figure-3: Structure of 19-crown-6-ether with decalino subunits (TD19C6) 
 
Another attempt to increase ionophore selectivity was made by Suzuki et 
al [9] who took a rational approach to ionophore design by considering 
molecular conformational factors.  
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Figure-4: Molecular Structure Design [9] 
Figures 3 and 4 show the results of these attempts. The molecule shown in 
Figure 3 was designed with a rigid frame and bulky block wall in order to 
prevent the formation of both a wrapping complex with smaller ions and a 
sandwich complex with larger ions.  
 
 
 
Figure-5: Structure of Tris (pyrazol-1-ylmethyl) benzene 
 14
Kim et al [4] reported high selectivity of tris (pyrazol-1-ylmethyl) benzene 
(Figure 5) for ammonium ion over alkali metal ions. Design factors 
included a consideration of the strong cation-π interaction provided by the 
phenyl rings and a rigid frame with a correctly sized cavity for binding. 
Tris (pyrazol-1-ylmethyl) benzene was highly selective for binding NH4+ 
over alkali metal ions via a cation-π interaction between the substrate and 
the central benzene ring of the receptor. In contrast to the nitrogen 
containing ionophores described above, the phenolic oxygens here (H-
bonding acceptors) have larger pKa values, potentially making the binding 
ability of this molecule less pH-dependent, an important factor in sensor 
performance for physiological applications.  
 
The ammonium ionophore currently used in commercial sensor 
applications is nonactin, [4, 6, 8, 9, 11, 15] a natural antibiotic (Figure 7). 
However, nonactin has serious drawbacks. Due to its flexibility, the 
binding site in nonactin can accommodate other ions particularly 
potassium which is a major interfering analyte (only ~10 times more 
selective for ammonium over potassium). In addition, nonactin can form 
wrapping type complexes with smaller ions. [6, 8, 11]  
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Figure-6: Structure of Nonactin 
 
We have undertaken the design and synthesis of new ammonium 
ionophores and fluoroionophores to address the drawbacks of nonactin, 
particularly the lack of selectivity. In particular, we have designed and 
modeled I, II, III.  
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Figure-7: Structures of Target molecules; I, II, III 
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Modeling studies that we report in this work predict 10-100 times better 
NH4+\K+ selectivity for these compounds as compared to Nonactin.  
 
The results of these studies are shown in Figure-8. Docking energies were 
determined on K+ and NH4+ complexes with various ammonium 
ionophores including I, II and III. Published selectivity data [7] and 
predicted selectivity of I were plotted as log NH4+\K+ selectivity vs. 
Docking energy as shown below. 
 
 
 
 
 Figure-8: Graph of Log NH4+/K+ selectivity vs. Docking Energy 
Log NH 4+/K+ Selectivity  Vs. ∆ Docking Energy (NH4+- K+ complexes) for various Ammonium 
Ionophores ( ) and Predicted Selectivities of Novel Ammonium Ionophores( •)
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In the figure-8 above [16], the tricyclic compounds are the most selective 
structures known today. (synthesized by Lehn and co-workers [7]). They 
show high selectivity but as mentioned above they can not be used for 
ammonium sensor applications due to irreversible complexation. In 
addition, nonactin and Bicyclic compound (BC-25) (synthesized by Lehn 
et al [7]) have poor selectivity for ammonium cations due to formation of 
weak complexes. 
 
We expect I, II and III will have high ammonium cation selectivity 
(theoretically 10-100 times more selective than nonactin) because they 
incorporate H-bond donors (amide groups) in tetrahedrally symmetric 
complexation sites. We also expect lower complexation constants leading 
to reversibility.  
 
In Figure-9, I is shown complexed with ammonium and potassium ions. 
When bound, the ammonium cation sits in the cavity of I with tetrahedral 
complexation and a minimum of four H-bonds. On the other hand, the 
potassium cation does not occupy a position in the cavity that is conducive 
to favorable complexation. 
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Figure-9: Complexation of I with NH4+ (down) and K+ (up) 
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While most ammonium sensors are currently electrochemical and in fact a 
major effort of our group is to fabricate ammonium ion selective 
electrodes, we have undertaken here the creation of an optical ammonium 
ionophore, or fluoroionophore. In order to use optical detection, our 
fluoroionophore will incorporate an anthracene chromophore covalently 
attached to the binding site at one of the secondary amines. This molecule 
will signal binding by an ‘off-on’ photoelectron transfer switching 
mechanism (PET).  
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Scheme-2: Model of Photo Electron Transfer Mechanism 
 
In ion-free conditions, the lone pair of electrons on the nitrogen atom 
connected to the anthracene will quench the anthracene excited state by 
electron transfer, leading to low fluorescence intensity. When ammonium 
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ion is bound, however, its electrostatic field will disrupt the transfer and 
cause fluorescence to increase dramatically in intensity. 
 
We report here the results of our efforts to design and synthesize I, II and 
III.  
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EXPERIMENTAL SECTION 
I) Materials  
All reagents were used as received without further purification. 
Dimethylformamide (DMF), 1,4 dioxane, diisopropylethylamine 
(DIPEA), piperidine, diethanolamine (99%), triethylamine (99.5%), and 
benzene (99%) were all purchased from Aldrich Chemicals. Coupling 
reagents (PyBOP, HOBt), Fmoc-OSu, using t-butyl-2,2,2 
trichloroacetimidate [TBTA]  and wang resin were purchased from Nova 
Biochem. δ-Aminovaleric acid-benzyl ester p-tosylate (3),N-β-
aminoethyl-Gly-OH (1) was purchased from BaChem. Fmoc-5-Ava-OH 
(5) was purchased from Advanced Chemtech. Diethyliminodiacetate(13), 
borontrifluoride (BF3.Et2O), thionyl chloride(99.5%), 5-aminovaleric 
acid(7)(97%), t-butanol(99.5%), 9-(chloro methyl)anthracene (98%), 
diaza-18-crown-6 (98%) was purchased from Acros. Anhydrous 
magnesium sulfate, chloroform was purchased from Mallinckrodt. 
Methanol, ethanol, dichloromethane (DCM) was purchased from 
Pharmco. Trifluoro-acetic acid (TFA) was purchased from J.T.Baker. 
Hexane was purchased from Burdick&Jackson. N-Fmoc-iminodiacetic 
acid was purchased from Fluka. Iminodiacetic acid was purchased from 
Avocado. 
 24
 
II) General Methods 
 
i) NMR 
1Proton nuclear magnetic resonance (1H NMR) spectra were obtained on a 
Bruker AVANCE 400 (400 MHz) NMR spectrometer.  Chemical shifts 
are reported in ppm (δ) relative to internal tetramethylsilane (TMS) at 0.00 
ppm.  13Carbon nuclear magnetic resonance (13C NMR) spectra were 
recorded at 100 MHz on the same spectrometer 
 
ii) Mass Spectrometry 
Mass spectra (electrospray) were performed by BAYER Corporation, MA. 
The system is a Waters QuattroMicro MS with ESI and uses a triple 
quadrapole. 
 
iii) Thin Layer Chromatography 
Analytical thin layer chromatography(TLC) was performed using pre-
coated  silica gel plates (Whatman 200 µm KCF18 silica gel 60A reverse 
phase plates or Whatman 250 µm thickness KF6F silica gel 60A normal 
phase plates) with visualization by UV-lamp or in a glass chamber 
containing iodine.  
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iv) Preparative Thin Layer Chromatography 
Preparative thin layer chromatography was performed using 1000 µm 
precoated Whatman PK6F 60 Å silica gel plates.  
 
v) Flash Chromatography 
Flash chromatography was performed on a Biotage Flash 12i using KP-Sil 
32-63 µm 60A silica gel under N2 pressure. 
 
vi) Melting Point 
All melting points were obtained using a Fisher-Johns Melting point 
apparatus and are uncorrected. 
 
vii) UV-Visible Spectroscopy 
Ground state absorption spectra were measured in a quartz cuvette (1cm x 
1cm) with a Shimadzu UV 2100 Spectrophotometer. Samples were 
measured in single beam mode and compared with a blank obtained with 
pure solvent.  
 
 26
viii) Molecular Modeling Calculations   
 Compounds I-II-III were designed by molecular modeling using the 
Molecular Operating Environment (MOE) program. Molecular modeling 
was performed on an SGI 320 running Windows NT. Calculations were 
carried out using the MOE program version 2000.02 computing package 
(Chemical Computing Group Inc., Montreal, Quebec, Canada). Structures 
were minimized first using the AMBER94 potential control under a 
solvent dielectric of 5. PEF95SAC was used to calculate partial charges. 
Molecular structures were then subjected to a 30 ps molecular dynamics 
simulation employing the NVT statistical ensemble. The bicyclic 
structures were heated to 400 K, equilibrated at 310 K (37 oC, Body 
Temperature) and cooled down to 290 K in the dynamics thermal cycle at 
a rate of 10 K/ps. 
  
   The lowest energies of the bicyclic structures obtained from these 
dynamics calculations were then minimized again. The same procedure 
applied to minimized bicyclic structures with NH4+ and K+ inside the 
cavity, respectively. The docking energies of ammonium and potassium 
cations were calculated by employing the default parameters supplied with 
the program. 
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ix) Kaiser Test: 
The Kaiser test is most widely used qualitative resin test for the presence 
or absence of free amino groups, especially primary amines. 
 
In order to perform the Kaiser test, a few dry resin beads were placed in a 
test tube and two drops of each of the solutions of  2 ml of a 0.001M 
aqueous solution of KCN dissolved in 98 ml pyridine, 80 g of liquefied 
phenol dissolved in 100 ml ethanol and 5 g of ninhydrin dissolved in 100 
ml ethanol were added to the test tube. 
 
We took the resulting pale yellow mixture, and heated it in an oven at 120 
oC for 5 minutes. If the resin beads appear clear or yellow at the end of 
this process, then there is no primary amine. However, if there is free 
unprotected amine, a dark blue solution will result [22].  
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III.Synthesis: 
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Scheme-3: Formation of 2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-
fluorenyl methoxy)carbonyl] aminoethyl)amino]acetic acid (2) 
 
i) 2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-fluorenyl methoxy) 
carbonyl]aminoethyl)amino]aceticacid(2)(Scheme-3): 
2-[(2-aminoethyl) amino] acetic acid (2g, 16.9 mmol) was dissolved in 40 
ml of 9% Na2CO3 solution. Fmoc-OSu (14.25 g, 42.25 mmol) in 120 ml 
1,4 Dioxane was added at once forming a suspension. The suspension was 
stirred over night at room temperature. The white precipitate was filtered 
and the filtrate was acidified with HCl up to pH: 2. After evaporating the 
solvents in vacuo, the solution was dissolved in 60 ml DI water. The 
solution was extracted thrice with 60 ml dichloromethane. The combined 
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organic extracts were dried with Na2SO4. After evaporating the solvent in 
vacuo, the crude was reprecipitated with dichloromethane: hexane (1:3) to 
give white solid (5.9 g, 62%). mp: 152.7 oC; Rf : 0.35 (1:15, Acetic acid: 
Dichloromethane); 1H-NMR: (400 MHz, CDCl3) δ 10.2(broad, 1H, 
COOH), 7.7(t, 2H, CH), 7.65(t, 2H, CH),7.49(d, 2H, CH), 7.4(d, 2H, CH), 
7.34(d, 2H, CH), 7.3(d, 2H, CH), 7.27(t, 2H, CH), 7.23(t, 2H, CH), 4.4(t, 
H, CH), 4.29(t, H, CH),4.1(d, 2H, CH2), 3.85(d, 2H, CH2), 3.73(s, 2H, 
CH2), 3.3&3.1(2H, CH2), 2.86(t, 2H, CH2);  13C-NMR:(100 MHz, MeOD) 
δ 40.51(CH2), 68.26(CH2), 69.43(CH2), 121.2(CH), 121.34(CH), 121.5 
(CH), 126.35(CH), 126.6(CH), 128.5(CH), 129.08(CH), 129.26(CH), 
142.98(C), 145.54(C), 145.65(C), 145.69(C),158.55(C=O), 159.3(C=O), 
173.8(COOH) EIS MS: m/z (M + H+) calcd. 562.62 found 562.96; (M + 
Na+) calcd.585.6 Found 585.008 
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 Scheme-4: Formation of Benzyl 5-(2-[[(9H-9-fluorenylmethoxy) 
carbonyl](2-[(9H-9-fluorenylmethoxy) carbonyl] aminoethyl)amino] 
acetylamino) pentanoate (4) 
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ii) Benzyl 5-(2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-fluorenyl 
methoxy)carbonyl]aminoethyl)amino]acetylamino)pentanoate(4): 
 2-[[(9H-9-fluorenyl methoxy) carbonyl](2-[(9H-9-fluorenyl methoxy) 
carbonyl]aminoethyl)amino] acetic acid(2) (1.125 g, 2 mmol), (Benzo 
triazol-1-yloxy)tris (pyrrolidino) phosphonium hexafluorophosphate [ 
PyBOP] (1.04 g, 2 mmol), 1-Hydroxybenzotriazole [HOBt] (0.27 g, 2 
mmol) and N,N-Diisopropyl ethylamine [DIPEA] (1.1 ml, 6 mmol) was 
dissolved in 100 ml dichloromethane. Amino valeric acid-benzyl ester- δ- 
p-tosylate (0.76 g, 2 mmol) in 50 ml dichloromethane was added to the 
solution, and the mixture was stirred in room temperature for 16 hrs. The 
solution was washed thrice with 5% NaHCO3 solution and thrice with 5% 
Citric acid solution. After dried with Na2SO4, the solvent was evaporated 
in vacuo. The crude was purified by reprecipitation with Dichloromethane: 
Hexane (1:3) to give a white solid (1.1 g, 73%). Rf: 0.45 (2:8 Hexane: 
Ethylacetate) mp.154.7 oC; 1H-NMR (400 MHz, CDCl3): δ 7.75-7.25 (m, 
21H, Aromatic CH), 5.07(s,2H,CH2), 4.48(d,2H,CH2), 4.34 (d,2H, CH2), 
4.17 (t,2H,CH), 3.75&3.58(d,2H,CH2), 3.23-3.08 (m,4H, CH2), 2.34 (m, 
2H, CH2), 1.67-1.25(m,4H,CH2) ; 13C-NMR(100 MHz, CDCl3): δ 22.34 
(CH2), 29.18(CH2), 33.99(CH2), 39.52(CH2), 40(CH2), 47.59(CH), 47.72 
(CH), 49.87(CH2), 52.56(CH2), 53.12(CH2), 66.8(CH2), 67.8(CH2), 120.37 
(CH), 125.19(CH),125.32(CH), 125.52(CH), 127.46(CH), 127.62(CH), 
128.08(CH), 128.21(CH), 128.63(CH), 128.69(CH),129(CH), 136(C), 
141.7(C), 144(C), 156.83(C=O), 169.85(C=O), 173.71(C=O) ;   
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EIS MS: m/z (M + H+) calcd. 751.8 found 752.236; (M + Na+) calcd. 
774.8 Found 775.226 (Scheme-4)   
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Scheme-5: Formation of tert-butyl 5-[(9H-9-fluorenyl methoxy) carbonyl] 
amino- pentanoate (6) 
 
iii)tert-butyl5-[(9H-9-fluorenylmethoxy)carbonyl]amino-pentanoate(6) 
(Scheme5): 5-[(9H-9-fluorenylmethoxy)carbonyl]aminopentanoic acid (5) 
(1 g, 3 mmol) and t-butyl-2,2,2 trichloroacetimidate [TBTA] (1.965 g, 9 
mmol) were dissolved in 100 ml Dichloromethane. After addition of 60 µl 
Boron trifluoride etherate [BF3.Et2O] (20 µl/mmol), the solution was 
stirred in room temperature for 24 hrs. After reaction was complete, a 
small amount of NaHCO3 crystals was added to solution. After filtration 
the crystals, the solvent was evaporated in vacuo. The crude was purified 
by column chromatography (7.5:2.5, Hexane: Ethylacetate) to give a 
yellowish white solid (2.49 mg, 21%). Rf: 0.49 (7.5:2.5 Hexane: 
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Ethylacetate);  mp.141.2 oC ; 1H-NMR: (400 MHz, CDCl3) δ 7.77(d, 2H, 
CH), 7.58(d, 2H,CH), 7.38(t, 2H,CH), 7.31(t, 2H,CH),  4.4(d,2H,CH2), 
4.21(t,1H,CH), 3.19(t,2H,CH2), 2.22(t,2H,CH2), 1.6(t,2H,CH2), 1.52 (t, 
2H,CH2), 1.44(t,9H,CH3) ; 13C-NMR(100 MHz, CDCl3): δ 22.48(CH2), 
28.5(CH3), 29.7(CH2), 35.39(CH2), 41.04(CH2), 47.6(CH2), 66.9(CH2), 
80.7(C), 120.37(CH), 125.47(CH), 127.43(CH), 128.06(CH), 141.7(C), 
144.3(C), 156.8(C=O), 173.3(C=O) EIS MS: m/z (M+Na+) calcd. 418.481  
Found 418.22 
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Scheme-6: Formation of tert-butyl 5-aminopentanoate(8)  
 
iv) tert-butyl 5-aminopentanoate(8)(Scheme-6):   
Thionyl Chloride (10 ml, 137.6 mmol) was added to 5-aminopentanoic 
acid(7) (5 g, 43 mmol) in dropwise. The solution was stirred in room 
temperature for 2 hrs. After evaporation of Thionyl Chloride in vacuo, the 
residue was dissolved in 100 ml 2-methyl-2-propanol(t-Butanol). The 
solution was stirred over night in room temperature. The solution was 
made basic (pH: 13-14) with saturated NaOH solution. The solution was 
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extracted thrice with 200 ml Dichloromethane, and then dried with 
Na2SO4. After evaporation of solvent in vacuo, the crude was purified by 
column chromatography (3:1:0.2, Dichloromethane: Methanol: Triethyl-
amine) to give a liquid (1.5 g, 20%). Rf: 0.3 (3:1:0.2 Dichloromethane: 
Methanol: Triethylamine) ; 1H-NMR: (400 MHz, CDCl3) δ 2.7(t,2H,CH2), 
2.25 (t,2H,CH2), 1.83(s, 2H,NH2), 1.64 (m, 2H, CH2),1.48(m,2H,CH2), 
1.44(s,9H,CH3) ; 13C-NMR: (100 MHz, CDCl3) δ 22.3 (CH2), 28.3(CH3), 
32.17(CH2), 35.73(CH2), 41.85(CH2), 80.22(C), 173.17(C=O) 
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Scheme-7: Formation of tert-butyl 5-(2-[[(9H-9-fluorenylmethoxy) 
carbonyl](2-[(9H-9-fluorenylmethoxy) carbonyl] amino ethyl) amino] 
acetyl amino) pentanoate(9) 
 
v) tert-butyl 5-(2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-
fluorenylmethoxy) carbonyl] amino ethyl) amino] acetyl amino) 
pentanoate (9) (Scheme-7): Mixture of 2-[[(9H-9-fluorenylmethoxy) 
carbonyl](2-[(9H-9-fluorenyl methoxy) carbonyl] amino ethyl) amino] 
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acetic acid (562 mg, 1 mmol), (Benzotriazol-1-yloxy) tris (pyrrolidino) 
phosphonium hexafluoro phosphate [PyBOP] (520 mg, 1 mmol), 1-
Hydroxybenzotriazole [HOBt] (135 mg, 1 mmol), and N, N-Diisopropyl 
ethylamine [DIPEA] (0.35 ml, 2 mmol) were dissolved in 40 ml 
chloroform. A solution of tert-butyl 5-aminopentanoate (175 mg, 1 mmol) 
in 5 ml chloroform was added to the mixture. The mixture was stirred at 
room temperature for 15 hrs. After removing the chloroform and base 
(DIPEA) in vacuo, the crude was washed thrice with 75 ml of 5 % of 
NaHCO3 solution, and thrice with 75 ml of 5 % citric acid solution. The 
combined organic extracts were dried with sodium sulfate and the solvent 
was removed in vacuo. The crude was purified by recrystalization in 
dichloromethane to give a white solid (490 mg, 68 %). Rf: 0.48 (2:8, 
Hexane-Ethyl Acetate) ; mp: 102.8 oC ; 1H-NMR(400 MHz, CDCl3): δ 
7.74(d, 4H, CH), 7.58(d, 2H, CH), 7.5(d, 2H, CH), 7.38(t, 4H, CH), 7.26(t, 
4H, CH), 6.08-5.75 (2H,CH), 4.5 (m,2H, CH2), 4.3(m, 2H, CH2), 4.19 (t, 
2H, CH2), 3.76 & 3.6(s,2H,CH2), 3.4(d,2H,CH2), 3.25-3.09(m,4H,CH2), 
2.2 (m, 2H, CH2),  1.57(t, 2H, CH2), 1.53(m, 2H, CH2), 1.47(m, 2H, CH2), 
1.42 (s,9H,CH3) 13C-NMR(100 MHz, CDCl3): δ 22.35(CH2), 26.87(CH2), 
28.48(CH3), 29.12(CH2), 35.15 (CH2), 39.58(CH2), 46.66(CH2), 47.58 
(CH2), 53.08(CH2), 67.83(CH2), 67.84(CH2), 80.7(C),  120.34(CH), 
125.15(CH), 125.28(CH), 125.5(CH), 127.43(CH), 127.6(CH), 128.04 
(CH), 128.18(CH), 141.68(C), 144.3(C), 156.56(C=O), 169.6(C=O), 
173.23 (2C=O) ;  EIS MS: m/z calcd.(M + H+) 717.86 found 718.164  
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Scheme-8: Formation of tert-butyl 5-(2-[(2-[5-(2-[[(9H-9-fluorenyl 
methoxy)carbonyl](2-[(9H-9 fluorenylmethoxy)carbonyl]amino ethyl) 
amino]acetyl amino) pentanoyl] amino ethyl)amino]acetyl amino) 
pentanoate (12) 
 
vi) tert-butyl 5-(2-[(2-[5-(2-[[(9H-9-fluorenylmethoxy)carbonyl](2-
[(9H-9 fluorenyl methoxy)carbonyl]amino ethyl)amino]acetyl amino) 
pentanoyl] amino ethyl)amino]acetyl amino)pentanoate(12)(Scheme-8) 
: Mixture of 5-(2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-fluorenyl 
methoxy) carbonyl] amino ethyl) amino]acetyl amino) pentanoic acid(11) 
(926.5 mg, 1.4 mmol), (Benzotriazol-1-yloxy)tris (pyrrolidino) 
phosphonium hexafluorophosphate [ PyBOP] (728 mg, 1.4 mmol), 1-
Hydroxybenzotriazole [HOBt] (189 mg, 1.4 mmol), and N,N-Diisopropyl 
ethylamine[DIPEA] (0.5 ml, 2.8 mmol) were dissolved in 25 ml 
chloroform. A solution of tert-butyl 5-(2-[(2-aminoethyl)amino]acetyl 
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amino) pentanoate(10) (382.7 mg, 1.4 mmol) in 35 ml chloroform was 
added to the mixture. The mixture was stirred at room temperature for 15 
hrs. After removing the chloroform and base (DIPEA) in vacuo, the crude 
was washed thrice with 75 ml of 5 % of NaHCO3 solution, and thrice with 
75 ml of 5 % citric acid solution. The combined organic extracts were 
dried with sodium sulfate and the solvent was removed in vacuo. The 
crude product was purified by flash chromatography (on silica gel) (8:1, 
Dichloromethane: Methanol, normal phase) to give white solid (350 mg, 
38%).  Rf: 0.5 (8:1, Dichloromethane: Methanol);  mp. 117.7 oC 
(Decomposition) ; 1H-NMR(400 MHz, CDCl3): δ 7.74(t,4H,CH), 7.57 (d, 
2H, CH), 7.5(d,2H,CH), 7.39(t,4H,CH), 7.27(d,4H,CH), 4.43(d,2H,CH2), 
4.33 (d,2H,CH2), 4.18(d,2H,CH), 3.82(d,2H,CH2), 3.48(t,2H,CH2), 3.3-
3.15(m,12H,CH2), 2.71(t,2H,CH2), 2.22-2.14(t,4H,CH2), 1.67-1.47(m, 6H, 
CH2), 1.42(s, 9H, CH3) ;  13C-NMR (100 MHz, CDCl3): δ 22.54(CH2), 
23.1 (CH2), 28.49(CH3), 28.94(CH2), 29.35(CH2), 30.1(CH2), 35.28(CH2), 
35.95 (CH2), 38.9(CH2), 39.16(CH2), 39.83(CH2), 40.1(CH2), 47.58(CH), 
49.67(CH2), 50.13(CH2), 52.72(CH2), 66.88(CH2), 67.98(CH2), 80.85(C),  
120.34(CH), 125.17(CH), 125.39(CH), 125.53(CH), 127.44(CH), 127.62 
(CH), 128.07(CH), 128.23(CH), 141.66(C), 144(C), 156.85(C=O), 172 
(C=O), 173.6(C=O) ; EIS MS: m/z (M + H+) calcd. 917.109 found 917.59; 
(M+Na+) calcd.940.1  Found 940.56 
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Scheme-9: Formation of  Ethyl 2-[(9-anthrylmethyl)(2-ethoxy-2-
oxoethyl) amino] acetate(14) 
 
vii) Ethyl 2-[(9-anthrylmethyl)(2-ethoxy-2-oxoethyl) amino] acetate 
(14) (Scheme-9) : Mixture of diethyliminodiacetate(13) (1 g, 5.7 mmol) 
and triethylamine (2 ml, 11.4 mmol) were dissolved in 50 ml 1,4 dioxane. 
A solution of 9-(chloro methyl) anthracene (1.42 g, 6.27 mmol) in 50 ml 
1,4 dioxane was added to the mixture. The mixture was heated to reflux 24 
hrs. After removing 1,4 dioxane and base (triethylamine) in vacuo, the 
crude was made basic with 1 N NaOH solution (100 ml), and the solution 
was extracted with thrice with 75 ml dichloromethane. The combined 
organic extracts were dried with sodium sulfate and the solvent was 
removed in vacuo. The remained diethyliminodiacetate (starting 
compound) was removed by Kugelrohr distillation in 4 hrs. After 
recrystalization in ethyl ether, the precipitate was filtered. The solvent in 
filtrate was removed in vacuo to give brownish gummy solid (1.75 g, 
81%) ; mp: 204  oC (Decomp.) ; 1H-NMR: (400 MHz, DMSO) δ 8.65 
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(d,2H,CH), 8.43(s,1H,CH), 7.98(d,2H,CH), 7.52(t,2H,CH), 7.47 (t, 2H, 
CH), 4.95(s,2H,CH2), 4.13(s,4H,CH2), 3.58(s,4H,CH2), 1.22(t,3H,CH3) ; 
13C-NMR: (100 MHz, DMSO) δ 14.88(CH3), 50(CH2), 54.81(CH2), 
61.14(CH2), 125.66(CH), 125.78(CH), 126.63(CH), 128.73(CH), 129.45 
(CH), 129.57 (C), 132.07(C), 132.38(C), 173.43(C=O) 
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Scheme-10: Formation of 2-[(9-anthrylmethyl)(carboxymethyl) amino] 
acetic acid (15) 
 
viii) 2-[(9-anthrylmethyl)(carboxymethyl) amino] acetic acid(15) 
(Scheme-10) : A solution of ethyl 2-[(9-anthrylmethyl)(2-ethoxy-2-
oxoethyl) amino] acetate(14) (450 mg, 1.2 mmol) in 20 ml ethanol was 
combined with 3 ml of 2N NaOH solution. The suspension was heated to 
reflux 6 hrs. After filtration of suspension, the precipitate was dissolved 
DI water and made basic with 2N NaOH solution. The solution was 
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washed with thrice with 50 ml dichloromethane. After making the solution 
acidic with 2N HCl solution, the suspension was filtered to give yellow 
solid (240 mg, 62%). mp. 179 oC ; 1H-NMR: (400 MHz, DMSO) δ 
12.37(s,1H,OH), 8.7(d,2H,CH), 8.6(s,1H,CH), 8.08(d,2H,CH), 7.5 (t, 4H, 
CH), 4.84(s,2H,CH2), 3.45(s,4H,CH2) ; 13C-NMR: (100 MHz, DMSO) δ 
49.46 (CH2), 54(CH2), 125.95(CH), 125.99(CH), 126.77(CH), 128.48 
(CH), 129.6(CH), 130.1 (CH), 131.78(C), 131.95(C), 173.54(COOH) 
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Scheme-11: Formation of 2-[(9-anthrylmethyl)(2-hydroxyethyl)amino]-1-
ethanol (17) 
 
ix)2-[(9-anthrylmethyl)(2-hydroxyethyl)amino]-1-ethanol(17) 
(Scheme-11) : Anthracene Chloride (5.47 g, 24.1 mmol) and Diethanol-
amine (16) (2.79 g, 26.5 mmol) were dissolved in 100 ml of 1,4 Dioxane. 
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After addition of triethylamine (10 ml, 52.5 mmol), the suspension was 
heated to reflux for 24 hours. The precipitate was filtered. After 
evaporation of 1,4 Dioxane from filtrate , the crude was redissolved and  
made basic with 2 N NaOH solution (pH: 12-14). The solution was 
extracted thrice with 50 ml Dichloromethane. After drying the combined 
organic extracts with Na2SO4, the solvent was evaporated in vacuo. The 
crude was purified by recrystalizing with Dichloromethane to give 
brownish solid (3.84 g, 54 %). mp: 116.8 oC ; 1H-NMR: (400 
MHz,CDCl3) δ 8.49 (s,1H,CH), 8.42(d,2H,CH), 7.98(d,2H,CH), 7.5 (t, 
2H, CH), 7.44(t,2H,CH),  4.67 (s,2H,CH2), 3.49(t,4H,CH2), 2.77 (t, 4H, 
CH2), 2.37 (s,1H,OH) ; 13C-NMR: (100 MHz, CDCl3) δ 51.9(CH2), 56.2 
(CH2), 60.05(CH2),124.6(CH), 125.35(CH), 126.65(CH), 128.5(CH), 
129.7 (CH), 131.6(C), 131.8(C), 134.5(C) 
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RESULTS AND DISCUSSION 
 
Three different amino acids were used to synthesize the monocyclic 
precursor compounds of the bicyclic final target molecules.  Each of the 
monocyclics contain four amino acids (either 1, 18, 7  depending on the 
final target). 
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2-[(2-aminoethyl)amino]aceticacid(1)
(2-Amino-ethoxy)-aceticacid(18)
5-aminopentanoic acid(7)
 
 
Figure-10: Structures of of 2-[(2-aminoethyl)amino]acetic acid(1), (2-
aminoethoxy)-acetic acid(18), 5-aminopentanoic acid(7) 
 
The monocyclic compounds contain two reactive sites (secondary amines) 
that facilitate addition of a bridging group to form the eventual bicyclic 
target compound. Therefore, all monocyclics contain at least two units of 
1. I is composed of four units of 1; II contains one each of 1 and 18; and 
III contains one each of 1 and 7. Figures 11-14 summarize I, II, III and 
their precursors. 
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Figure 11: I,II,III and Aminoacids 
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Synthetic Strategies: 
 
Previous studies show that the bicyclic peptides can be synthesized by two 
strategies; Strategy-I involves building a linear peptide with two protected 
side chains. Cyclization of the linear chain then yields the cyclic peptide. 
Deprotection of the two side chains and coupling with the bridge yields 
the bicyclic target which can then be further functionalized by addition of 
the chromophore if desired. The scheme-12 for Strategy-I is shown below; 
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Scheme-12  : Strategy-I for Synthesizing Bicyclic Structures
 48
Strategy-II involves synthesis of the linear peptide, cyclization and then 
addition of the bridge and chromophore in one step.  The scheme-13 for 
strategy-II is below; 
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Synthesis of bicyclic peptides I-II-III was attempted using this second 
strategy. The advantage here is that the starting materials are either easily 
prepared or available commercially. In this method, the bridging unit has a 
point of attachment for the chromophore that will be used in the optical 
signaling of ion binding  
 
The major problem in the synthesis of this monocyclic compound is that 1 
contains two reactive sites which are primary and secondary amines. 
There is no completely effective strategy that can protect only secondary 
amines or only primary amines in a mixture of secondary and primary 
amines. Therefore it can be anticipated that preparation of the target 
molecule will result in a significant number of side products. One method 
that could provide at least some differentiation between primary and 
secondary amines is benzaldehyde protection, shown in Scheme-14 below 
[17];  
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Scheme-14: Benzaldehyde protection reaction 
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The reaction of benzaldehyde with a molecule containing primary and 
secondary amines forms a five membered ring which results in only the 
primary amine remaining reactive for further coupling. However, 
deprotection of the five membered ring in subsequent steps can lead to 
side reactions or cleavage of the linear molecule.  For example, reaction 
with benzaldehyde[19] can form side products that contain an imine 
function instead of a ring function (Scheme 15). 
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Scheme-15: Formation of Imine compound 
 
Considering that the primary amine is more reactive than the secondary 
amine in coupling reactions a one-to-one ratio of the two peptides would 
likely yield the monocyclic peptide as the major product. The easiest 
system to synthesize should be III because 7 is commercially available and 
does not contain a secondary amine. 
  
There are two general methods to synthesize the monocyclic compounds; 
solid phase peptide synthesis (SPPS) and solution phase peptide synthesis.  
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III: 
 
Trial-I:  
The decision to use Solid Phase Peptide Synthesis (SPPS) for the synthesis 
of bicyclic III is based on a well known method. It usually provides high 
yields and relatively pure products, because all excess reagents are easily 
removed by washing the resin with different solvents.[20,21] Solid Phase 
Peptide Synthesis (SPPS) is based on sequential addition of amino acids 
and side chain protected amino acid residues to a variety of possible 
insoluble resins (solid or polymeric supports). The only requirements for 
the resin are their stability in the solvent systems used and toward the 
coupling reagents as well as the ability to easily cleave the peptide from 
the resin at the end of the synthesis. With this method, only a few 
reactions and procedures are repeatedly used: swelling the resin; removal 
of protecting groups; coupling with protected amino acids; and cleaving 
the peptide from the support.[21,22] 
 
The general scheme of SPPS is below; 
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Synthetic Route 
The decision to use Fmoc as a protecting group is due to its high coupling 
efficiency leading to easy purification [23] and the commercial availability 
of Fmoc-protected amino acids. For the solid support, a Wang Resin was 
chosen since cleavage from this resin does not involve basic conditions 
that would remove Fmoc groups.  
 
 
OH
O
P
Figure-15: Wang Resin (100-200 mesh)
 
 
[ P : polymer matrix(copoly(styrene-1 % DVB), 100-200 mesh] 
 
The structures of the coupling reagents that were used during the SPPS, 
are below; 
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Figure-16: Coupling Reagents 
 
The synthetic route is below; 
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ii) Synthesis, Results and Discussion for the SPPS route : 
For SPPS of bicyclic peptides, it was necessary to protect 1 with Fmoc 
groups. The reaction was performed according to the procedure described 
in the literature and given in detail in the experimental section.[24]  
 
Solid phase synthesis was carried out on 1 g of Wang resin [100-200 
mesh] (loading 0.5-1.30 mmol/g resin). The resin was stirred under N2 in 
DMF for 30 minutes in order to swell the resin. DMF was removed by 
filtration. During this time, 5 (1.7 g, 5 mmol) was mixed with 
Diisopropylcarbodiimide (0.783g, 5 mmol) in DCM in a round bottom 
flask. The solution was stirred for 30 minutes and the DCM was removed 
under vacuo. The dried residue was dissolved in DMF and the solution 
was subsequently added to the resin. 4-Dimethylaminopyridine (DMAP) 
(12.27 mg, 0.1 mmol) was added as a catalyst and the mixture was stirred 
under N2 for 2 hours. After this, the acid function of the amino acid was 
attached to the resin while the amine function of the amino acid was still 
protected with the Fmoc-protecting group. 
 
The reaction solution was filtered off and the resin was washed three times 
each with DMF and methanol, once with ethanol and dried under vacuo. 
The loading was tested by cleaving the Fmoc-protection group from a 
known mass of resin (20 mg) with 20% piperidine in DMF and monitoring 
the UV absorption at 290 nm. The cleaved Fmoc group forms fluorene 
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which absorbs UV light at 290 nm. The loading of the resin was calculated 
according to the following formula; 
 
 A = const * b * [C] 
 
Here, the constant is the molar extinction coefficient, b is the path length 
in centimeters and [C] is the concentration of the fluorene. The absorbance 
yields the concentration of the fluorene allowing calculation of the amount 
of amino acid attached to the resin. Our results indicated a loading of ~100 
%.  
 
The remaining resin was reswelled again in DMF for 10 min. After 
washing the resin with DMF again, the Fmoc-protecting group was 
cleaved with 20 % piperidine in DMF for 10 min. The solution was 
filtered off and the resin washed three times with DMF. 2 (1.47 g, 2.5 
mmol) and coupling reagents; PyBOP (1.3 g, 2.5 mmol), HOBt (0.338g, 
2.5 mmol), and Diisopropylethylamine (DIPEA) (0.87 ml, 5 mmol) were 
dissolved in DMF. The mixture was then added to the resin and stirred 
overnight with N2. The solution was filtered off and the resin was washed 
three times with DMF, three times with methanol, once with ethanol and 
dried under vacuo. Complete coupling was confirmed by the Kaiser test 
for free amine. 
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The general procedure was repeated again for addition of 5 (0.68 g, 2 
mmol), and 2 (1.17 g, 2 mmol) respectively. After each Fmoc-
deprotection, the resin was washed three times each with DMF MeOH, 
DMF,and EtOH and dried under vacuo. After the last coupling and 
deprotection step, the resin was transferred into a round bottom flask and 
stirred in 95% TFA solution for 3 hours. The resin was removed by 
filtration. The TFA in the filtrate was evaporated to a final volume of 5 ml. 
The crude peptide was precipitated with ethyl ether to give 100 mg of 
white crystals. MS of the white crystals [Appendix-A], a mixture of two 
major compounds(24 and 23(Linear Peptide)) was obtained. 
 
Further analysis of crude the mixture with HPLC showed two major and 
one minor product in the crude mixture. One of the two major products 
was the desired linear peptide (23) (MW:416.516).But obviously, there 
was also  a product that resulted from a double coupling during the third 
coupling step. The excess of 5 not only coupled with primary amine but 
also with unprotected secondary amine. The result was a branched peptide 
(24) according to the figure-17 below with a MW: 615.766. 
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Figure-17: Structures of 23 (Linear Peptide) and 24 (Branched peptide) 
Low yield and difficulty in purification of the crude mixture of SPPS 
forced the use of solution phase peptide synthesis. 
 
Trial II: 
i) Synthetic Route 
In order to use a solution phase approach for the synthesis of peptides, a 
second protecting group for the protection of the acid function is 
necessary. We chose the benzyl-ester protecting group because it is stable 
to the cleavage conditions for the Fmoc group and can be easily removed 
by H2/Pd on activated carbon.  
 
The coupling reagents were the same as used in SPPS. The synthetic route 
is shown below. 
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Scheme-18: Synthetic Route for solution phase synthesis with benzylester 
protection 
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ii) Synthesis, Results and Discussion  
3 [δ-aminovaleric acid-benzyl ester p-tosylate] is commercial while 2 was 
synthesized according to the procedure described in the experimental 
experimental section.  
 
In a round bottom flask, 2 was coupled with 3 according to the procedure 
for 4 described in the experimental section. The crude mixture was 
purified by reprecipitation with dichloromethane: hexane (1:3) to give a 
white solid (4).  
 
The resulting compound (4) was divided in half with one half undergoing 
deprotection of the Fmoc group and the other half undergoing deprotection 
of the benzylester group.  Fmoc deprotection of 4 was performed in the 
same way as in the solid phase approach described above. The product, 
25, was used without further purification.  
 
For deprotection of  the benzyl ester group 4 was dissolved in chloroform 
and the emulsion was stirred under H2 gas at room temperature for 3 hours 
after addition of palladium on activated carbon. After filtration of the Pd 
and evaporating the solvents, a crude mixture was obtained. Analysis of 
the crude mixture with prep-TLC and H-NMR showed that one product 
was fluorene indicating that the  Fmoc is at least partially cleaved during 
the benzylester deprotection step. MS of the crude mixture[Appendix-A] 
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showed the presence of three compounds - starting material(4) (MW: 
751.865), expected product(11) (MW: 661.743) and the product with the 
benzylester group and one of the Fmoc protecting groups removed (MW: 
439.504); 
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N
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O O
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27
28
 
Formula Weight = 439.504 
Figure-18: Structures of Products from Benzylester Deprotection 
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This method did not work properly and in further deprotection of Benzyl 
ester, we could face deprotection problem again. 
 
Trial-III: 
 
Low yield and deprotection of Fmoc during the deprotection of benzyl 
ester forced us to switch to solution phase peptide synthesis with a 
different acid protection group. 
 
i) Synthetic Route 
We chose to use tert-Butyl protection of the acid function of 7 because it 
can be easily removed by 50% TFA solution and it is stable to the 
conditions for Fmoc deprotection.  The coupling reagents were the same 
used in SPPS. The synthetic route is shown below. 
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Scheme-19: Synthetic Route for Solution P.P.S. with t-Butylester 
Protection 
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ii) Synthesis, Results and Discussion  
It was necessary to protect 5 with the tert-Butyl protecting group using t-
butyl-2,2,2 trichloroacetimidate [TBTA]. The reaction was performed 
according to the procedure described by Armstrong, A.[26] However, this 
two step reaction was found to have a low yield. Taylor and coworkers 
[27] synthesized tert-butyl p-aminobenzoate from 4-amino benzoic acid 
by using thionyl chloride and t-butanol. 
 
 
OH
NH2
O
O
NH2
O
CH3
CH3
CH3
1) SOCl2
2) t-Butanol
 
 
Scheme-20: Sample t-Butylester protection reaction 
 
This reference reaction was reasonable to synthesize the tert-butyl 
protected amino acid-III (8) from this procedure. 8 was synthesized 
according to the procedure described in the experimental part. 8 was 
coupled with 2 according to the procedure described in the experimental 
part in order to get half linear peptide.  
 
The resulting compound(9) was splitted into two parts. One part 
designated to undergo Fmoc deprotection to give 10 according to the 
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procedure described in SPPS. The other part designated to undergo tert-
Butyl deprotection to give 11. 9 was dissolved in  50% trifloroacetic acid 
(TFA) solution (v/v, chloroform) and stirred at room temperature for 45 
min. After removing the solvent and acid, 11 was obtained and it was used 
further reactions without purification.  
 
After deprotection reactions, we synthesized 12 by coupling 11 (tert-Butyl 
deprotected) with 10 (Fmoc deprotected). The coupling procedure and 
reagents were the same used in SPPS. After coupling reaction, the crude 
was purified by flash chromatography to give white solid (12). The 
coupling yield was low(38%) if we compared previous coupling reactions 
because we had primary amine with secondary amine in 10 which could 
react with the acid function of 11.  
 
Before further cyclization of the linear, and then synthesis of the bicyclic 
peptide, we decided to perform a sample reaction that was putting a bridge 
onto a commercial cycle that could have two secondary amine. We found 
1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane [Cycle-IV] that was; 
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Figure-19: Structure of 1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane 
(Cycle-IV) 
 
This azacrown could be a sample for us because it has two secondary 
amines and it was composed of 18 atoms. 
 
SAMPLE BICYCLIC :   
 
In literature, E. Simmons and C. H. Park [28] synthesized bicyclic 
structures by putting a bridge that has two acid chloride arms, on to the 
cycle. The reaction scheme-21 was below; 
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Scheme-21: Sample Reaction for Formation of Bicyclic Structures 
 
At this point, we would find a commercial bridge compound that would be 
similar to bridge-I.  
 
Trial- I: 
 
i) Synthetic Route 
We tried to synthesize 15 by using imino-diaceticacid  according to the 
procedure described in Organikum.[29] 
 
The synthetic route was below; 
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Scheme-22: Synthetic Route-I for IV 
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ii) Synthesis, Results and Discussion  
Anthracene Chloride(1.25 eq)  and Iminodiacetic acid(29)  were dissolved 
in acetonitrile and the solution was reflux for 4 hours after addition of 
triethylamine. After evaporation of solvent and base, the crude was 
obtained. 
 
The NMR spectras of prep-TLC layers of the crude showed that the 
reaction did not work. We predicted that during the reaction, carboxylic 
acid parts could neutralize the secondary amine and prevent the anthracene 
chloride reaction with secondary amine. 
 
Trial II: 
 
i) Synthetic Route 
In order to synthesize 15, a protecting group for the protection of the acid 
function is necessary. We chose the ethyl-ester protecting group because it 
is stable to anthracene chloride reaction conditions and can be easily 
removed by saponification reaction.  
  
The synthetic route was below; 
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Scheme-23: Synthetic Route-I for IV 
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ii) Synthesis, Results and Discussion  
14 was synthesized by using 13 and anthracene chloride, and 30 was 
synthesized by saponification process of 14. The procedures of these two 
reactions were described in the experimental part. 
 
 (Anthracen-9-ylmethyl-carboxymethyl-amino)diaceticacid (15) was 
dissolved in excess thionyl chloride and the mixture was heated to reflux 
for 30 min. After evaporating thionyl chloride, the solid was mixed with 
cycle-IV (1 eq) in excess benzene(more than 100 ml). After adding 
triethylamine, the mixture was stirred under N2 at room temperature for 24 
hrs. After evaporating base and benzene, the crude was dissolved in  
2 N NaOH solution and extracted with DCM. After drying the combined 
organic phase with MgSO4 and evaporating the solvent, the crude mixture 
was obtained. 
 
The purification by using normal phase prep-TLC or doing normal phase 
TLC was really hard because anthracene was high fluorescent character 
and the anthracene compounds showed a lot of dots in normal phase TLC. 
The mass-spectra of the crude showed that the reaction did not work and 
we had only starting materials left. 
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Trial III: 
 
We could struggle to synthesize the bicyclic structure but we would face 
the purification problem of the bicyclic compound due to high fluorescent 
character of anthracene group. But, if we synthesize the bicylic structure 
which bridge amine group was protected by Fmoc protecting group, we 
could add anthracene after cleaving Fmoc group and we could easily 
purify the crude by removing the anthracene chloride (starting material) 
and HCl (only side product).  
 
i) Synthetic Route 
We found commercially Fmoc protected aminodiacetic acid (31). We 
chose the Fmoc protecting group because it was stable to the reaction 
conditions (acidic, HCl) and could be easily removed by %20 piperidine 
solution.   
 
The synthetic route was below; 
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Scheme-24: Synthetic Route for V and IV 
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ii) Synthesis, Results and Discussion  
N-Fmoc-iminodiacetic acid (31) was dissolved in excess thionyl chloride 
and the mixture was heated to reflux for 30 min. After evaporating thionyl 
chloride, the solid was mixed with cycle-IV (1 eq) in excess benzene. We 
made a very dilute solution in order to get a good yield. After addition of 
DIPEA(3 eq), the mixture was stirred under N2 at room temperature for 7 
hours. We used DIPEA as a base instead of triethylamine that was 
described in literature because DIPEA has bulky groups that could not 
cleave Fmoc protection. After evaporating the solvent and base, the crude 
was redissolved in dichloromethane and washed  with 2 N HCl solution. 
The organic phase was dried with MgSO4. We used MgSO4 for drying 
instead of Na2SO4 because Mg has a large size than Na or NH4+ that can 
not fit to the cavity of the bicyclic compound. The purification is in 
progress. 
 
 
BRIDGE COMPOUND: 
 
During the cycle reactions, we tried to synthesize the bridge-I. In the 
bridge compound, there should be fluorescent groups and two reaction 
parts for putting the bridge compound onto the cycles. We tried to 
synthesize the bridge-I; 
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Figure-20: Structure of Bridge-I
 
 
i) Synthetic Route 
We chose anthracene group due to having high fluorescent character, and 
the tosylate due to being very good leaving group. The reaction was done 
according to the procedure in  Organikum.[29] 
 
 The synthetic route was below; 
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Scheme-25: Synthetic Route for Bridge-I 
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ii) Synthesis, Results and Discussion  
17 was synthesized by using anthracene chloride and diethanolamine(16) 
according to the procedure described in the experimental part. 
 
ii-A) Tosylation Reaction: 
 
Trial I: 
In a round bottom flask, p-Toluenesulfonylchloride (2.25 eq) were mixed 
with 2-[(9-anthrylmethyl) (2-hyroxyethyl) amino]-1-ethanol (17) in 
chloroform and the mixture was stirred a few minutes and cooled below 5 
oC. This cooling was due to heat production. After addition of 
triethylamine in dropwise to the solution, the mixture was stirred at room 
temperature for 3 hours. A mixture of 6 g ice and 2.4 ml conc. HCl was 
added carefully to the solution, and then the mixture was stirred at room 
temperature for 30 min. The chloroform part was washed with DI water. 
After drying with Na2SO4,and evaporating the solvent, the yellowish 
brown solid was obtained. The H-NMR and C-NMR spectras showed that 
this brownish solid was the same as starting compound. 
 
Trial II: 
We tried the same procedure but we heated the mixture to reflux for 3 hrs 
instead of stirring in room temperature for 3 hours. The NMR spectras 
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showed that the reaction did not work again. We got only starting material 
left. 
 
In literature, one tosylate attachment to alcohols gave good yields. But, in 
our case, the two tosylate attachment did not work. We predicted that one 
tosylate attached to the bridge arms could prevent the other attachment by 
its bulky character. 
 
 Further reactions for bridge compound, we could use other good leaving 
groups that do not have bulky character, for instance; mesolate, halogens 
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CONCLUSION: 
III was tried to synthesize in three different ways, and the linear that will 
form the cycle-III after cyclization, was synthesized recently. Up to now,  
Benzyl 5-(2-[[(9H-9-fluorenylmethoxy)carbonyl](2-[(9H-9-fluorenyl 
methoxy) carbonyl] aminoethyl)amino]acetylamino)pentanoate (4), tert-
butyl 5-[(9H-9-fluorenyl methoxy)carbonyl]amino- pentanoate (6), t-butyl 
5-(2-[[(9H-9-fluorenyl methoxy)carbonyl](2-[(9H-9-fluorenylmethoxy) 
carbonyl] amino ethyl) amino]acetyl amino) pentanoate (9), tert-butyl 5-
(2-[(2-[5-(2-[[(9H-9-fluorenylmethoxy) carbonyl] (2-[(9H-9 
fluorenylmethoxy)carbonyl]amino ethyl)amino]acetyl amino) pentanoyl] 
amino ethyl)amino]acetyl amino)pentanoate (12), ethyl 2-[(9-
anthrylmethyl)(2-ethoxy-2-oxoethyl) amino] acetate (14), 2-[(9-
anthrylmethyl)(carboxymethyl) amino] acetic acid (15) which were not in 
literature, were synthesized. Future work will focus on; 
 
• Synthesizing Bicyclic-V 
• Synthesizing Bicyclic-IV from Bicyclic-V 
• Cyclization the linear peptide(12) 
• Synthesizing the Bridge-I 
• Synthesizing III 
 
After synthesizing the bicyclic molecules, their photophysical properties 
in the presence of ammonium cation will be characterized.  
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APPENDIX-A 
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